Look at the general biotech market. The NBI is down 122 points. This is continued backlash from the abbvie/gild price war imho. To be honest, Ariad is holding up better than normal.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.